arrow
A

Ana Fortuna

Universidade do Porto
H指数:2
被引数:37

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

De-Escalated Chemotherapy and Endocrine Therapy Outcomes in Young Women with Stage I HR+/HER2+ Breast Cancer: An International Real-World Study.

在年轻女性中,针对I期HR+/HER2+乳腺癌的降级化疗和内分泌治疗效果:一项国际真实世界研究。

2026-06-110
OAAI
Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy.

辅助性卵巢功能抑制和芳香化酶抑制剂在激素受体和HER2阳性乳腺癌绝经前患者中的应用,按化疗和曲妥珠单抗的时机及新辅助治疗的反应。

2025-12-060
OAAI
Sleep-disordered breathing and aggressiveness markers of cutaneous melanoma. A multicentric study
2016-11-080
PRE